LN

Lizzie Ngo

Founding President at Weaver Biosciences

Greater Boston

Overview 

Lizzie Ngo is a Principal at Longwood Fund in Greater Boston, with a background in lifesciences and technology development. She has held key roles at Weaver Biosciences as Founding President and Photys Therapeutics as Director and Founding VP, showcasing her expertise in DNA repair and biochemistry. Ngo's career highlights include being a Co-Chair of New Technology Special Interest Group at the Environmental Mutagenesis and Genomics Society and serving as a VentureLabs Summer Fellow at Flagship Pioneering, demonstrating her leadership in the field of lifesciences and venture capital.

Work Experience 

  • Founding President

    2024 - Current

  • Director Board of Directors

    2022

  • Founding VP Strategy & Ops

    2021 - 2022

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.

Raised $75,000,000.00 from Longwood Fund, MRL Ventures Fund, 8VC, Omega Funds, MPM Capital, Mass General Brigham Ventures, Eli Lilly & Company Foundation, Heritage Medical Systems, Arkin Bio Ventures and Ono Venture Investment.

  • Principal

    2022

  • Senior Associate

    2020 - 2022

Longwood Fund finances science-based companies that develop novel solutions for medical problems.

  • Associate

    2018 - 2020

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Postdoctoral Research Associate

    2018 - 2018

    • Lead translation of anti-cancer drug screening platform as continuation in PhD lab. • Founded and led NSF-funded MIT i-Corps team of 5 to explore commercial potential of technology. • Conducted >20 market research interviews. Wrote and won grant ($3,000) to support this effort. • Selected for Snapshot Pitch in front of 80+ industry experts. • Led startup team to semi-final pitch at Sloan Healthcare Innovation Prize. • Designed curriculum and organized speakers for MIT and Harvard-funded BiomedStartup course. • Raised $750K in grant funding for commercialization of carcinogenic DNA damage detection tool.

  • PhD in Biological Engineering

    2011 - 2018

    • Developed new cell-based assays with significant improvement compared to current standard for cell survival (250-fold reduced materials, 80% improved speed, and 90% reduced labor time) and DNA damage (500% increased sensitivity and 1000-fold increased speed). • Named inventor on worldwide patent application for new cell survival quantification technology. • Raised $300K in grant funding for applications of DNA repair in personalized cancer treatment. • Mentored 5 undergraduates and taught biotech class with 30 students.

  • VentureLabs Summer Fellow

    2018 - 2018

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Co-Chair of New Technology Special Interest Group

    2017 - 2018

    • Design meeting content and coordinate speakers for annual meeting. • Created “What’s new in biotech?“ segment and gave first presentation.

  • Scarlet Listeners Supervisor

    2010 - 2011

    • Provided emotional support and referrals to over 50 callers. • Trained 20+ new counselors and supervised a team of 4.

Articles About Lizzie

Relevant Websites